5:54 PM
 | 
Dec 05, 2013
 |  BC Extra  |  Clinical News

Receptos jumps on RADIANCE update for RPC1063

Receptos Inc. (NASDAQ:RCPT) jumped $4.94 (22%) to $27.64 on Thursday after announcing that a DMC recommended continuing the Phase II portion...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >